Indian stocks: Visit www.stage2stocks.com →

Haleon plc

Stage 4 · Declining · week 4

As of Oct 22, 2026, Haleon is in Stage 4, the downtrend phase, now in week 4 (since Sep 28, 2026). It closed at $10.37, 6.2% below its 52-week high and above its 200-day average, which is falling.

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin… More about the company

$10.37
+3.49% today
$45.6B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is HLN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 35w
S3 14w
S2 22w
S4 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 6w → S3 4w → S4 5w → S1 9w → S2 1w → S1 2w → S3 3w → S2 35w → S3 14w → S2 22w → S3 5w → S4 14w → S1 8w → S2 11w → S3 4w → S4 10w → S1 5w → S2 4w → S4 4w current
Total tracked: 166 weeks across 19 stage runs.

HLN among Drug Manufacturers - Specialty & Generic22nd of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…22HLNStage 4 · wk 465+13.8%
vs 52W High
-6.2%
$8.64 lo$11.05 hi
6.2% below 52W high, failed near resistance
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 4
1w13w26w
Week 4, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
7.1%
200 DMA: $9.68 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.92x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+13.8%
3M
+6.7%
6M
+9.5%
YTD
+5.8%
1Y
+13.4%
Scan Membership
Breakout Watch
Latest: 2025-02-21
5 appearances in last 60 days. First seen: 2023-05-09.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 4 · Vol 0.92x
2026-10-21S4
Wk 4 · Vol 0.78x
2026-10-20S4
Wk 4 · Vol 1.21x
2026-10-19S4
Wk 4 · Vol 1.33x
2026-10-16S4
Wk 3 · Vol 1.20x
2026-10-15S4
Wk 3 · Vol 1.24x
2026-10-14S4
Wk 3 · Vol 0.94x
2026-10-13S4
Wk 3 · Vol 0.92x
2026-10-12S4
Wk 3 · Vol 1.34x
2026-10-09S4
Wk 2 · Vol 0.78x
2026-10-08S4
Wk 2 · Vol 1.38x
2026-10-07S4
Wk 2 · Vol 1.24x
Moving averages & range
50 DMA
$9.55
200 DMA
$9.68
52W High
$11.05
52W Low
$8.64
5D Low
$10.02
Resistance levels (recent highs)
20d High
$10.37
60d High
$10.37
120d High
$10.37
250d High
$11.05
Next resistance
+6.6%
to 250d High
P/E (TTM)
21.2
Forward 16.8
Earnings Growth (YoY)
-4.5%
Revenue +2.2%
ROE
+10.1%
Profit margin +14.6%
Dividend Yield
1.98%
P/B 2.1

Haleon: quick answers

What stage is Haleon in?

As of Oct 22, 2026, Haleon (HLN) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 28, 2026 and is in week 4. What the four stages mean

Is Haleon in an uptrend?

No. Haleon is in a Stage 4 downtrend. It trades 7.1% above its 200-day average, which is falling.

How far is Haleon from its 52-week high?

Haleon closed at $10.37 on Oct 22, 2026, 6.2% below its 52-week high of $11.05. Its 52-week low is $8.64.

How has Haleon performed over the past year?

As of Oct 22, 2026, Haleon is up 13.4% over the past year and up 5.8% so far in 2026.

Which sector and industry is Haleon in?

Haleon is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.